Ayala Pharmaceuticals Inc (ADXS)

[James salmon]

This is what's important, not some of the negative bashing done;

Cynthia Frazier, of Beech Island, will soon watch one grandchild graduate from college while another graduates from high school. She might have an experimental cervical cancer vaccine to thank for being around for that.

Frazier, 54, was one of 11 patients who participated in a clinical trial at the Georgia Cancer Center at Augusta University to help find the right dose. That first phase has now become a much larger, international clinical trial of the ADXS11-001 cervical cancer vaccine.

Frazier was diagnosed in 2013 when a Pap smear turned up the original cancer. She seemed to respond to the standard treatment, but at the end she had lesions in her lungs. The vaccine therapy she later received got her enough response that now Ghamande can try some other options if the cancer progresses again.

“The time she has gotten out of this vaccine is pretty remarkable,” he said.

Frazier said she told her daughter about undertaking the vaccine trial.

“She said, ‘Mom you can look back and say you helped somebody else, too,’” Frazier said. “Everything is going good.”